Coronary Heart Disease (CHD) is a leading cause of morbidity and mortality in the United States and the world. The broad, long-term goal of our research is to dissect the complex genetic architecture of Coronary Heart Disease (CHD), which will subsequently lead to better prediction and treatment of this devastating disease. We hypothesize that amino acid variants, their interactions with each other, and with the environment will play an important role in the complex etiology of CHD. We expect that in order to unravel the genetic architecture of CHD, we must go beyond the additive model. To determine the role of amino acid variants in CHD, we will use a novel approach to acquire genotype data for a comprehensive set of uncommon (0.010.01) amino acid variants in the full ARIC study. We will use whole- exome sequence data in a subset of 1500 ((1000 EA, ~500 AA) participants from the Atherosclerosis Risk in Communities (ARIC) study and an additional 7500 from the NHLBI Exome Sequencing Project (ESP) and the CHARGE-S project in conjunction with GWAS data to impute a comprehensive set of amino acid variants in the entire ARIC cohort. To analytically dissect the complex architecture of lipid profiles and CHD in this subset of SNPs, we will go beyond the simple models used in GWAS screening into more sophisticated models that fall into three categories. First, a single locus model that is generalized to allow the full range of genetic effects (not just additive). Second, two locus models that test for gene-by-gene interactions. Third, test for genotype- by-sex interactions. Sequence uncertainty and imputation probability will be incorporated into each analysis. Using this novel approach, for the first time, a comprehensive set of uncommon to common amino acid variants will be analyzed in a large sample and in multiple ethnic populations for their association with lipid profiles and incident CHD.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Hasan, Ahmed AK
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
George Washington University
Schools of Arts and Sciences
United States
Zip Code
Maxwell, Taylor J; Corcoran, Chris; Del-Aguila, Jorge L et al. (2018) Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels. Alzheimers Res Ther 10:86
Hong, Chuan; Ning, Yang; Wei, Peng et al. (2017) A semiparametric model for vQTL mapping. Biometrics 73:571-581
Cao, Ying; Maxwell, Taylor J; Wei, Peng (2015) A family-based joint test for mean and variance heterogeneity for quantitative traits. Ann Hum Genet 79:46-56
Cao, Ying; Wei, Peng; Bailey, Matthew et al. (2014) A versatile omnibus test for detecting mean and variance heterogeneity. Genet Epidemiol 38:51-59
Xue, Cheng; Liu, Xiaoming; Gong, Yun et al. (2013) Significantly fewer protein functional changing variants for lipid metabolism in Africans than in Europeans. J Transl Med 11:67
Maxwell, Taylor J; Ballantyne, Christie M; Cheverud, James M et al. (2013) APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions. Genetics 195:1397-405
Xue, Cheng; Huang, Ren; Maxwell, Taylor J et al. (2010) Genome changes after gene duplication: haploidy vs. diploidy. Genetics 186:287-94